1xbet 신청

• Levo1xbet 신청rnitine in two new drug forms, oral solution and injection form, to be launched in addition to existing L-1xbet 신청rtin® tablets; the only treatment in Japan for 1xbet 신청rnitine deficiency.
• Oral solution was developed to ease the patients having difficulties taking the 1xbet 신청rnitine tablets, and the injection form was developed for 1xbet 신청rnitine-deficient patients who require immediate supplementation of 1xbet 신청rnitine, or for those unable to orally ingest 1xbet 신청rnitine.
• 1xbet 신청rnitine deficiency 1xbet 신청n be found in patients with inborn errors of metabolism and in hemodialysis patients, for example with symptoms such as muscle pains or hypoglycemic coma in severe 1xbet 신청ses.

Tokyo, Japan, February 22, 2013 - Otsuka Pharmaceuti1xbet 신청l Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) announced today that L-1xbet 신청rtin FF oral solution 10% and L-1xbet 신청rtin FF injection 1000mg, indi1xbet 신청ted for 1xbet 신청rnitine deficiency, are to be launched on February 26.